{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:27Z","timestamp":1761513747838,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.clbc.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T05:29:34Z","timestamp":1546752574000},"page":"e276-e282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Significance of Serum Survivin and -31G\/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt"],"prefix":"10.1016","volume":"19","author":[{"given":"Tarek M.K.","family":"Motawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia I.","family":"Zakhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebatallah A.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan M.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer A.","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.01.002_bib1","first-page":"1101","article-title":"[Breast cancer and obesity, a dangerous relation]","volume":"8","author":"Zaman","year":"2012","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.clbc.2019.01.002_bib2","doi-asserted-by":"crossref","first-page":"dju305","DOI":"10.1093\/jnci\/dju305","article-title":"Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer","volume":"106","author":"Garcia-Closas","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.01.002_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12282-015-0609-8","article-title":"Molecular epidemiology, and possible real-world applications in breast cancer","volume":"23","author":"Ito","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2019.01.002_bib4","first-page":"437971","article-title":"Cancer incidence in Egypt: results of the national population-based cancer registry program","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"J\u00a0Cancer Epedemiol"},{"key":"10.1016\/j.clbc.2019.01.002_bib5","first-page":"399","article-title":"Survivin as a novel target protein for reducing the proliferation of cancer cells","volume":"8","author":"Li","year":"2018","journal-title":"Biomed Rep"},{"key":"10.1016\/j.clbc.2019.01.002_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/bem.21849","article-title":"A\u00a0moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells","volume":"35","author":"Lin","year":"2014","journal-title":"Bioelectromagnetics"},{"key":"10.1016\/j.clbc.2019.01.002_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/14756366.2012.762645","article-title":"Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3","volume":"29","author":"Motawi","year":"2014","journal-title":"J\u00a0Enzyme Inhib Med Chem"},{"key":"10.1016\/j.clbc.2019.01.002_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3892\/ol.2016.4718","article-title":"hTERT and BIRC5 gene promoters for cancer gene therapy: a comparative study","volume":"12","author":"Shepelev","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clbc.2019.01.002_bib9","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3892\/ol.2015.3507","article-title":"Association between functional variants in BIRC5\/survivin gene 3\u2032 untranslated region and mRNA expression in lymphoblastoid cell lines","volume":"10","author":"Pu","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clbc.2019.01.002_bib10","first-page":"935","article-title":"Survivin promoter -31G\/C polymorphism in oral cancer cell lines","volume":"2","author":"de Maria","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clbc.2019.01.002_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2008.09.048","article-title":"Association between survivin gene promoter -31 C\/G polymorphism and urothelial carcinoma risk in Taiwanese population","volume":"73","author":"Wang","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.clbc.2019.01.002_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00432-009-0575-7","article-title":"Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma","volume":"135","author":"Yang","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.002_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lungcan.2007.09.008","article-title":"Polymorphisms in the survivin gene and the risk of lung cancer","volume":"60","author":"Jang","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clbc.2019.01.002_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.suronc.2011.01.001","article-title":"Survivin expression and targeting in breast cancer","volume":"21","author":"Jha","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clbc.2019.01.002_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1582-4934.2005.tb00361.x","article-title":"Survivin as a target for new anticancer interventions","volume":"9","author":"Zaffaroni","year":"2005","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.clbc.2019.01.002_bib16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3892\/mmr.2014.2371","article-title":"Variation in Sp1 binding sites correlates with expression of survivin in breast cancer","volume":"10","author":"Xu","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clbc.2019.01.002_bib17","first-page":"7426","article-title":"Correlation between survivin genetic polymorphisms and lung cancer susceptibility","volume":"8","author":"Guo","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clbc.2019.01.002_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2407-13-356","article-title":"Functional promoter -31G\/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case\u2013control study","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2019.01.002_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/dna.2012.1912","article-title":"Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population","volume":"32","author":"Li","year":"2013","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.clbc.2019.01.002_bib20","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.4238\/2013.February.28.9","article-title":"Association between survivin gene promoter -31G\/C and -644C\/T polymorphisms and non-small cell lung cancer","volume":"12","author":"Aynaci","year":"2013","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.clbc.2019.01.002_bib21","doi-asserted-by":"crossref","first-page":"e28829","DOI":"10.1371\/journal.pone.0028829","article-title":"Functional promoter -31G > C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population","volume":"7","author":"Qin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2019.01.002_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1245\/s10434-010-1371-y","article-title":"Role of survivin gene promoter polymorphism (-31G > C) in susceptibility and survival of esophageal cancer in northern India","volume":"18","author":"Upadhyay","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.01.002_bib23","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1016\/j.clbc.2017.11.011","article-title":"Role of the functional polymorphism of survivin gene (-31G\/C) and risk of breast cancer in a North Indian population","volume":"18","author":"Rasool","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2019.01.002_bib24","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3906\/biy-1405-78","article-title":"The effect of survivin gene promoter polymorphism on breast cancer","volume":"38","author":"Altiparmak","year":"2014","journal-title":"Turk J Biol"},{"key":"10.1016\/j.clbc.2019.01.002_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2298\/SARH1306304K","article-title":"Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development","volume":"141","author":"Kosti\u0107","year":"2013","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.clbc.2019.01.002_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10238-010-0122-5","article-title":"Survivin -31C\/G polymorphism and gastric cancer risk in a Brazilian population","volume":"11","author":"Borges Bdo","year":"2011","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.clbc.2019.01.002_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jcp.2006.037804","article-title":"Survivin promoter polymorphism and cervical carcinogenesis","volume":"60","author":"Borbely","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clbc.2019.01.002_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2407-14-176","article-title":"Early diagnostic value of survivin and its alternative splice variants in breast cancer","volume":"14","author":"Khan","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2019.01.002_bib29","first-page":"1511","article-title":"Expression, clinical significance and correlation of survivin and p53 in breast cancer","volume":"8","author":"Yu-qian","year":"2013","journal-title":"Biotechnol Indian J"},{"key":"10.1016\/j.clbc.2019.01.002_bib30","first-page":"100","article-title":"The role of survivin in diagnosis, prognosis and treatment of breast cancer","volume":"2","author":"Lv","year":"2010","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.clbc.2019.01.002_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10585-006-9037-7","article-title":"Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA","volume":"23","author":"Yie","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.clbc.2019.01.002_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00432-013-1524-z","article-title":"Association between survivin -31G > C polymorphism and cancer risk: meta-analysis of 29 studies","volume":"140","author":"Qin","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.002_bib33","first-page":"165","article-title":"Serum HER-2\/neu and survivin levels and their relationship to histological parameters in early-stage breast cancer","volume":"35","author":"Goksel","year":"2007","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.clbc.2019.01.002_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1385\/MO:23:3:335","article-title":"Serum and urine survivin levels in breast cancer","volume":"23","author":"Guney","year":"2006","journal-title":"Med Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918307043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918307043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:17:28Z","timestamp":1761513448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820918307043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1526820918307043"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.01.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Serum Survivin and -31G\/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}